Investors Ride 5 Earnings Rollercoaster Rides

Cepheid (NASDAQ:CPHD) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share decreased 0% to $0.02 in the quarter versus EPS of $0.02 in the year-earlier quarter. Revenue Rose 18.49% to $96 million from the year-earlier quarter.

Cepheid reported adjusted EPS income of $0.02 per share. By that measure, the company beat the mean analyst estimate of $-0.04. It beat the average revenue estimate of $92.57 million.

CPHD

ICU Medical, Inc. (NASDAQ:ICUI) delivered a profit and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share decreased 23.81% to $0.48 in the quarter versus EPS of $0.63 in the year-earlier quarter. Revenue Rose 1.84% to $78.7 million from the year-earlier quarter.

ICU Medical, Inc. reported adjusted EPS income of $0.48 per share. By that measure, the company missed the mean analyst estimate of $0.66. It missed the average revenue estimate of $83.44 million.

ICUI

Chemed Corp. (NYSE:CHE) delivered a profit and beat Wall Street’s expectations, BUT came up short on beating the revenue expectation. Adjusted Earnings Per Share increased 14.29% to $1.44 in the quarter versus EPS of $1.26 in the year-earlier quarter. Revenue Rose 0.86% to $357.2 million from the year-earlier quarter.

Chemed Corp. reported adjusted EPS income of $1.44 per share. By that measure, the company beat the mean analyst estimate of $1.33. It missed the average revenue estimate of $368.06 million.

CHE

Align Technology Inc. (NASDAQ:ALGN) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share increased 5.88% to $0.36 in the quarter versus EPS of $0.34 in the year-earlier quarter. Revenue Rose 12.5% to $163.83 million from the year-earlier quarter.

Align Technology Inc. reported adjusted EPS income of $0.36 per share. By that measure, the company beat the mean analyst estimate of $0.28. It beat the average revenue estimate of $156.2 million.

ALGN

Quest Diagnostics Inc. (NYSE:DGX) delivered a profit and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share decreased 9.4% to $1.06 in the quarter versus EPS of $1.17 in the year-earlier quarter. Revenue Decreased 4.81% to $1.82 billion from the year-earlier quarter.

Quest Diagnostics Inc. reported adjusted EPS income of $1.06 per share. By that measure, the company missed the mean analyst estimate of $1.09. It missed the average revenue estimate of $1.84 billion.

DGX

Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.

More Articles About:   , ,  

More from The Cheat Sheet